Interleukin	B-protein
12	I-protein
induces	O
tyrosine	O
phosphorylation	O
and	O
activation	O
of	O
STAT4	B-protein
in	O
human	B-cell_type
lymphocytes	I-cell_type
.	O

Interleukin	B-protein
12	I-protein
(	O
IL-12	B-protein
)	O
is	O
an	O
important	O
immunoregulatory	B-protein
cytokine	I-protein
whose	O
receptor	O
is	O
a	O
member	O
of	O
the	O
hematopoietin	B-protein
receptor	I-protein
superfamily	I-protein
.	O

We	O
have	O
recently	O
demonstrated	O
that	O
stimulation	O
of	O
human	B-cell_type
T	I-cell_type
and	I-cell_type
natural	I-cell_type
killer	I-cell_type
cells	I-cell_type
with	O
IL-12	B-protein
induces	O
tyrosine	O
phosphorylation	O
of	O
the	O
Janus	B-protein
family	I-protein
tyrosine	I-protein
kinase	I-protein
JAK2	B-protein
and	O
Tyk2	B-protein
,	O
implicating	O
these	O
kinases	B-protein
in	O
the	O
immediate	O
biochemical	O
response	O
to	O
IL-12	B-protein
.	O

Recently	O
,	O
transcription	B-protein
factors	I-protein
known	O
as	O
STATs	B-protein
(	O
signal	B-protein
transducers	I-protein
and	I-protein
activators	I-protein
of	I-protein
transcription	I-protein
)	O
have	O
been	O
shown	O
to	O
be	O
tyrosine	O
phosphorylated	O
and	O
activated	O
in	O
response	O
to	O
a	O
number	O
of	O
cytokines	B-protein
that	O
bind	O
hematopoietin	B-protein
receptors	I-protein
and	O
activate	O
JAK	B-protein
kinases	I-protein
.	O

In	O
this	O
report	O
we	O
demonstrate	O
that	O
IL-12	B-protein
induces	O
tyrosine	O
phosphorylation	O
of	O
a	O
recently	O
identified	O
STAT	B-protein
family	I-protein
member	I-protein
,	O
STAT4	B-protein
,	O
and	O
show	O
that	O
STAT4	B-protein
expression	O
is	O
regulated	O
by	O
T-cell	O
activation	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
IL-12	B-protein
stimulates	O
formation	O
of	O
a	O
DNA-binding	B-protein
complex	I-protein
that	O
recognizes	O
a	O
DNA	O
sequence	O
previously	O
shown	O
to	O
bind	O
STAT	B-protein
proteins	I-protein
and	O
that	O
this	O
complex	O
contains	O
STAT4	B-protein
.	O

These	O
data	O
,	O
and	O
the	O
recent	O
demonstration	O
of	O
JAK	B-protein
phosphorylation	O
by	O
IL-12	B-protein
,	O
identify	O
a	O
rapid	O
signal-transduction	O
pathway	O
likely	O
to	O
mediate	O
IL-12	B-protein
-induced	O
gene	O
expression	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

92	NULL
,	NULL
Pp	NULL
.	NULL

7307-7311	NULL
,	NULL
August	NULL
1995	NULL
Immunology	NULL
Interleukin	NULL
12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
STATA	NULL
in	NULL
human	NULL
lymphocytes	NULL
(	NULL
cytokine	NULL
signal	NULL
transduction	NULL
/transcription	NULL
factor	NULL
)	NULL
CHRIS	NULL
M	NULL
.	NULL

Bacon*t	NULL
?	NULL

,	NULL
EmanuEL	NULL
F.	NULL
PErRicom	NULL
III§	NULL
,	NULL
JouNn	NULL
R.	NULL
RoseRt	NULL
C.	NULL
ReEst	NULL
,	NULL
AnprEw	NULL
C.	NULL
LarnERS	NULL
,	NULL
JAMES	NULL
A.	NULL
JounstoN*	NULL
,	NULL
aND	NULL
Jon	NULL
J.	NULL
O'SHEa*	NULL
*Lymphocyte	NULL
Cell	NULL
Biology	NULL
Section	NULL
,	NULL
Arthritis	NULL
and	NULL
Rheumatism	NULL
Branch	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Arthritis	NULL
and	NULL
Musculoskeletal	NULL
and	NULL
Skin	NULL
Diseases	NULL
,	NULL
Building	NULL
10	NULL
,	NULL
Room	NULL
IN262	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
;	NULL
*Institute	NULL
For	NULL
Cancer	NULL
Studies	NULL
,	NULL
University	NULL
of	NULL
Sheffield	NULL
Medical	NULL
School	NULL
,	NULL
Sheffield	NULL
,	NULL
South	NULL
Yorkshire	NULL
,	NULL
S10	NULL
2RX	NULL
,	NULL
United	NULL
Kingdom	NULL
;	NULL
$	NULL
Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Center	NULL
for	NULL
Biologics	NULL
Evaluation	NULL
and	NULL
Research	NULL
,	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
;	NULL
and	NULL
``	NULL
Laboratory	NULL
of	NULL
Experimental	NULL
Immunology	NULL
,	NULL
Biological	NULL
Response	NULL
Modifiers	NULL
Program	NULL
,	NULL
National	NULL
Cancer	NULL
Institute-Frederick	NULL
Cancer	NULL
Research	NULL
and	NULL
Development	NULL
Center	NULL
,	NULL
Frederick	NULL
,	NULL
MD	NULL
21702	NULL
Communicated	NULL
by	NULL
William	NULL
E.	NULL
Paul	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
,	NULL
May	NULL
10	NULL
,	NULL
1995	NULL
ABSTRACT	NULL
Interleukin	NULL
12	NULL
(	NULL
IL-12	NULL
)	NULL
is	NULL
an	NULL
important	NULL
im-munoregulatory	NULL
cytokine	NULL
whose	NULL
receptor	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
hematopoietin	NULL
receptor	NULL
superfamily	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
stimulation	NULL
of	NULL
human	NULL
T	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
with	NULL
IL-12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
Janus	NULL
family	NULL
tyrosine	NULL
kinases	NULL
JAK2	NULL
and	NULL
Tyk2	NULL
,	NULL
implicating	NULL
these	NULL
kinases	NULL
in	NULL
the	NULL
immediate	NULL
biochemical	NULL
response	NULL
to	NULL
IL-12	NULL
.	NULL

Recently	NULL
,	NULL
transcription	NULL
factors	NULL
known	NULL
as	NULL
STATs	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
)	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
a	NULL
number	NULL
of	NULL
cytokines	NULL
that	NULL
bind	NULL
hematopoietin	NULL
receptors	NULL
and	NULL
activate	NULL
JAK	NULL
kinases	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
demonstrate	NULL
that	NULL
IL-12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
recently	NULL
identified	NULL
STAT	NULL
family	NULL
member	NULL
,	NULL
STAT4	NULL
,	NULL
and	NULL
show	NULL
that	NULL
STAT4	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
T-cell	NULL
activation	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
that	NULL
IL-12	NULL
stimulates	NULL
formation	NULL
of	NULL
a	NULL
DNA-binding	NULL
complex	NULL
that	NULL
recognizes	NULL
a	NULL
DNA	NULL
sequence	NULL
previously	NULL
shown	NULL
to	NULL
bind	NULL
STAT	NULL
proteins	NULL
and	NULL
that	NULL
this	NULL
complex	NULL
contains	NULL
STAT4	NULL
.	NULL

These	NULL
data	NULL
,	NULL
and	NULL
the	NULL
recent	NULL
demonstration	NULL
of	NULL
JAK	NULL
phosphorylation	NULL
by	NULL
IL-12	NULL
,	NULL
identify	NULL
a	NULL
rapid	NULL
signal-transduction	NULL
pathway	NULL
likely	NULL
to	NULL
mediate	NULL
IL-12-induced	NULL
gene	NULL
expression	NULL
.	NULL

Interleukin	NULL
12	NULL
(	NULL
IL-12	NULL
)	NULL
is	NULL
a	NULL
monocyte/macrophage-derived	NULL
cytokine	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
,	NULL
which	NULL
,	NULL
through	NULL
its	NULL
many	NULL
effects	NULL
on	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
and	NULL
T	NULL
lymphocytes	NULL
,	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
initiation	NULL
and	NULL
control	NULL
of	NULL
cell-mediated	NULL
immune	NULL
responses	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

The	NULL
receptor	NULL
for	NULL
IL-12	NULL
(	NULL
IL-12R	NULL
)	NULL
is	NULL
incompletely	NULL
characterized	NULL
,	NULL
although	NULL
a	NULL
low-affinity	NULL
subunit	NULL
has	NULL
recently	NULL
been	NULL
cloned	NULL
(	NULL
5	NULL
)	NULL
.	NULL

This	NULL
subunit	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
hematopoietin	NULL
receptor	NULL
family	NULL
,	NULL
closely	NULL
related	NULL
to	NULL
gp130	NULL
.	NULL

Like	NULL
other	NULL
family	NULL
members	NULL
,	NULL
binding	NULL
of	NULL
IL-12	NULL
to	NULL
the	NULL
IL-12R	NULL
induces	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
range	NULL
of	NULL
intracellular	NULL
substrates	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
hematopoietin	NULL
receptors	NULL
do	NULL
not	NULL
possess	NULL
intrinsic	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
but	NULL
instead	NULL
associate	NULL
with	NULL
and	NULL
activate	NULL
members	NULL
of	NULL
the	NULL
Janus	NULL
(	NULL
JAK	NULL
)	NULL
family	NULL
of	NULL
cytoplasmic	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
8-12	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
IL-12	NULL
treatment	NULL
of	NULL
human	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
leads	NULL
to	NULL
the	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
JAK2	NULL
and	NULL
Tyk2	NULL
kinases	NULL
,	NULL
implicating	NULL
these	NULL
kinases	NULL
in	NULL
the	NULL
immediate	NULL
biochemical	NULL
response	NULL
to	NULL
IL-12	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
biological	NULL
effects	NULL
of	NULL
IL-12	NULL
include	NULL
the	NULL
rapid	NULL
activation	NULL
of	NULL
early-response	NULL
genes	NULL
such	NULL
as	NULL
interferon	NULL
y	NULL
(	NULL
IFN-y	NULL
)	NULL
and	NULL
perforin	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
,	NULL
but	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
IL-12	NULL
might	NULL
stimulate	NULL
transcription	NULL
are	NULL
not	NULL
known	NULL
.	NULL

A	NULL
number	NULL
of	NULL
recent	NULL
studies	NULL
have	NULL
identified	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
called	NULL
STAT	NULL
's	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcrip-tion	NULL
)	NULL
,	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
signal-transduction	NULL
cascades	NULL
of	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

7307	NULL
many	NULL
cytokines	NULL
known	NULL
to	NULL
activate	NULL
JAK	NULL
kinases	NULL
(	NULL
8	NULL
,	NULL
13-15	NULL
)	NULL
.	NULL

Originally	NULL
described	NULL
as	NULL
mediators	NULL
of	NULL
IFN-induced	NULL
transcrip-tion	NULL
,	NULL
STATs	NULL
are	NULL
latent	NULL
cytoplasmic	NULL
transcription	NULL
factors	NULL
that	NULL
,	NULL
after	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
bind	NULL
specific	NULL
,	NULL
but	NULL
related	NULL
,	NULL
DNA	NULL
sequences	NULL
to	NULL
promote	NULL
transcription	NULL
of	NULL
cytokine-responsive	NULL
genes	NULL
(	NULL
13	NULL
)	NULL
.	NULL

IFN-	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT2	NULL
,	NULL
which	NULL
associate	NULL
with	NULL
a	NULL
nuclear	NULL
48-kDa	NULL
DNA-binding	NULL
protein	NULL
to	NULL
form	NULL
a	NULL
multiprotein	NULL
transcriptional	NULL
activator	NULL
known	NULL
as	NULL
interferon-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IFN-y	NULL
promotes	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
homodimerization	NULL
of	NULL
STAT1	NULL
,	NULL
which	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
directly	NULL
binds	NULL
to	NULL
a	NULL
conserved	NULL
sequence	NULL
motif	NULL
termed	NULL
the	NULL
IFN-y-activation	NULL
site	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Ligand	NULL
binding	NULL
to	NULL
many	NULL
hematopoietin	NULL
receptors	NULL
has	NULL
now	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
family	NULL
proteins	NULL
,	NULL
thereby	NULL
promoting	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
IFN-y-activation	NULL
site-related	NULL
DNA	NULL
sequences	NULL
:	NULL
the	NULL
IL-6	NULL
family	NULL
of	NULL
cytokines	NULL
activate	NULL
both	NULL
STAT1	NULL
and	NULL
STAT3	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
,	NULL
prolactin	NULL
activates	NULL
STAT1	NULL
(	NULL
21	NULL
)	NULL
and	NULL
STATS	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
IL-4	NULL
activates	NULL
a	NULL
STAT	NULL
protein	NULL
designated	NULL
IL-4-STAT	NULL
(	NULL
STAT6	NULL
)	NULL
(	NULL
23	NULL
)	NULL
.	NULL

STAT4	NULL
is	NULL
another	NULL
family	NULL
member	NULL
with	NULL
restricted	NULL
distribution	NULL
,	NULL
being	NULL
expressed	NULL
mainly	NULL
by	NULL
myeloid	NULL
cells	NULL
and	NULL
developing	NULL
spermatogonia	NULL
and	NULL
also	NULL
in	NULL
thymus	NULL
and	NULL
spleen	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
no	NULL
STAT4-activating	NULL
ligand	NULL
has	NULL
been	NULL
identified	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
STAT	NULL
proteins	NULL
could	NULL
be	NULL
identified	NULL
in	NULL
the	NULL
signal-transduction	NULL
pathway	NULL
of	NULL
IL-12	NULL
.	NULL

Stimulation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
with	NULL
IL-12	NULL
induced	NULL
early	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT4	NULL
but	NULL
not	NULL
of	NULL
STAT1	NULL
or	NULL
STAT2	NULL
.	NULL

Moreover	NULL
,	NULL
electrophoretic	NULL
mobility-shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
identified	NULL
an	NULL
IL-12-induced	NULL
DNA-binding	NULL
complex	NULL
that	NULL
contained	NULL
STATA4	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
IL-12	NULL
might	NULL
activate	NULL
transcription	NULL
by	NULL
inducing	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT4	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cytokines	NULL
and	NULL
Antibodies	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-12	NULL
(	NULL
4.5	NULL
X	NULL
10°	NULL
units/mg	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Stanley	NULL
Wolf	NULL
(	NULL
Genetics	NULL
Institute	NULL
;	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
;	NULL
recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
3	NULL
x	NULL
10°	NULL
Cetus	NULL
units/mg	NULL
)	NULL
by	NULL
Cetus	NULL
Oncology	NULL
;	NULL
recombinant	NULL
human	NULL
IFN-a	NULL
(	NULL
2.4	NULL
x	NULL
10°	NULL
units/mg	NULL
)	NULL
by	NULL
Hoffmann-La	NULL
Roche	NULL
;	NULL
and	NULL
recombinant	NULL
human	NULL
IL-4	NULL
and	NULL
IL-6	NULL
by	NULL
PeproTech	NULL
(	NULL
Rocky	NULL
Hill	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
antisera	NULL
against	NULL
STAT4	NULL
(	NULL
C-20	NULL
and	NULL
L-18	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
antisera	NULL
against	NULL
STAT1	NULL
and	NULL
STAT2	NULL
were	NULL
provided	NULL
by	NULL
Chris	NULL
Schindler	NULL
(	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
Abbreviations	NULL
:	NULL
NK	NULL
,	NULL
natural	NULL
killer	NULL
;	NULL
STAT	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
IFN	NULL
,	NULL
interferon	NULL
;	NULL
GRR	NULL
,	NULL
IFN-y	NULL
response	NULL
element	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglutinin	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
;	NULL
IL-12SF	NULL
,	NULL
IL-12-stimulated	NULL
factor	NULL
;	NULL
IL-12R	NULL
,	NULL
IL-12	NULL
receptor	NULL
;	NULL
ISRE	NULL
,	NULL
IFN-a-stimulated	NULL
response	NULL
element	NULL
.	NULL

*To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
sent	NULL
at	NULL
the	NULL
*	NULL
address	NULL
.	NULL

7308	NULL
Immunology	NULL
:	NULL
Bacon	NULL
et	NULL
al	NULL
.	NULL

York	NULL
)	NULL
.	NULL

Monoclonal	NULL
anti-phosphotyrosine	NULL
antibody	NULL
,	NULL
clone	NULL
4G10	NULL
,	NULL
was	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Activation	NULL
.	NULL

Normal	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
94	NULL
+	NULL
5	NULL
%	NULL
CD3*	NULL
)	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
by	NULL
Percoll	NULL
gradient	NULL
centrifugation	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Fresh	NULL
NK	NULL
cells	NULL
were	NULL
negatively	NULL
selected	NULL
from	NULL
low-density	NULL
Percoll	NULL
fractions	NULL
using	NULL
anti-CD3	NULL
antibodies	NULL
coupled	NULL
to	NULL
magnetic	NULL
beads	NULL
(	NULL
MACS	NULL
;	NULL
Miltenyi	NULL
Biotechnology	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

To	NULL
induce	NULL
IL-12	NULL
responsiveness	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
3	NULL
days	NULL
in	NULL
RPMI	NULL
1640	NULL
medium/10	NULL
%	NULL
fetal	NULL
calf	NULL
serum/phytohem-agglutinin	NULL
(	NULL
PHA	NULL
)	NULL
at	NULL
2	NULL
pg/ml	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
split	NULL
1:1	NULL
with	NULL
fresh	NULL
medium	NULL
,	NULL
and	NULL
then	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
day	NULL
with	NULL
IL-2	NULL
at	NULL
50	NULL
international	NULL
units/ml	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
line	NULL
Kit	NULL
225	NULL
(	NULL
subclone	NULL
K6	NULL
)	NULL
(	NULL
28	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Hoffmann-La	NULL
Roche	NULL
and	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium/10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
/IL-2	NULL
at	NULL
100	NULL
international	NULL
units/ml	NULL
.	NULL

Before	NULL
stimulation	NULL
with	NULL
cytokines	NULL
,	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
Kit	NULL
225/K6	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
acidified	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
pH	NULL
6.4	NULL
)	NULL
and	NULL
rested	NULL
for	NULL
4	NULL
hr	NULL
in	NULL
RPMI	NULL
1640	NULL
medium/0.5	NULL
%	NULL
human	NULL
AB	NULL
serum	NULL
or	NULL
2	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
respec-tively	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Immunoblotting	NULL
.	NULL

Cell	NULL
lysis	NULL
in	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
buffer	NULL
,	NULL
immunoprecipitation	NULL
with	NULL
anti-STAT	NULL
antisera	NULL
,	NULL
and	NULL
subsequent	NULL
SDS/PAGE	NULL
were	NULL
done	NULL
as	NULL
described	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Immunoblotting	NULL
with	NULL
anti-phosphotyrosine	NULL
antibody	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
6	NULL
)	NULL
.	NULL

For	NULL
immunoblotting	NULL
with	NULL
anti-STAT	NULL
antisera	NULL
,	NULL
membranes	NULL
were	NULL
blocked	NULL
in	NULL
Tris/borate/	NULL
saline	NULL
containing	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
and	NULL
5	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
,	NULL
incubated	NULL
sequentially	NULL
with	NULL
primary	NULL
antibody	NULL
and	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
,	NULL
and	NULL
detected	NULL
using	NULL
enhanced	NULL
chemiluminescence	NULL
.	NULL

When	NULL
a	NULL
membrane	NULL
was	NULL
reprobed	NULL
,	NULL
it	NULL
was	NULL
first	NULL
treated	NULL
with	NULL
15	NULL
%	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
.	NULL

EMSA	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
cytokine-stimulated	NULL
cells	NULL
as	NULL
described	NULL
(	NULL
29	NULL
)	NULL
.	NULL

EMSAs	NULL
were	NULL
done	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
30	NULL
)	NULL
using	NULL
a	NULL
*°P-end-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
(	NULL
5-AGCATGTTTCAAGGATTT-GAGATGTATTTCCCAGAAAAG-3	NULL
'	NULL
)	NULL
corresponding	NULL
to	NULL
the	NULL
IFN-y	NULL
response	NULL
element	NULL
(	NULL
GRR	NULL
)	NULL
of	NULL
the	NULL
human	NULL
Fey	NULL
receptor	NULL
I	NULL
(	NULL
FeyRI	NULL
)	NULL
gene	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
whole-cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
labeled	NULL
probe	NULL
in	NULL
binding	NULL
buffer	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
before	NULL
A	NULL
B	NULL
Competitor	NULL
:	NULL
IL-12	NULL
3	NULL
g	NULL
2	NULL
®	NULL
o	NULL
5°	NULL
150	NULL
450	NULL
to	NULL
=	NULL
IL-12	NULL
SF-	NULL
»	NULL
I	NULL
,	NULL
C-	NULL
»	NULL
IL-12SF	NULL
-	NULL
i	NULL
B	NULL
-	NULL
»	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
electrophoresis	NULL
on	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
autoradiogra-phy	NULL
.	NULL

When	NULL
used	NULL
,	NULL
antibodies	NULL
were	NULL
incubated	NULL
with	NULL
cell	NULL
extracts	NULL
for	NULL
60	NULL
min	NULL
at	NULL
4°C	NULL
before	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

Competitive	NULL
inhibition	NULL
was	NULL
performed	NULL
by	NULL
incubating	NULL
100-fold	NULL
excesses	NULL
of	NULL
unlabeled	NULL
GRR	NULL
or	NULL
the	NULL
IFN-a-stimulated	NULL
response	NULL
element	NULL
(	NULL
ISRE	NULL
)	NULL
of	NULL
interferon-stimulated	NULL
gene	NULL
15	NULL
(	NULL
5'-GATCCATGC-CTCGGGAAAGGGAAACCGAAACTGAAGCC-3	NULL
'	NULL
)	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
with	NULL
cell	NULL
extracts	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
before	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Like	NULL
many	NULL
other	NULL
members	NULL
of	NULL
the	NULL
hematopoietin	NULL
receptor	NULL
family	NULL
,	NULL
the	NULL
IL-12	NULL
receptor	NULL
is	NULL
functionally	NULL
coupled	NULL
to	NULL
members	NULL
of	NULL
the	NULL
JAK	NULL
family	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
IL-12	NULL
treatment	NULL
of	NULL
PHA-activated	NULL
human	NULL
T	NULL
cells	NULL
induces	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
Tyk2	NULL
and	NULL
JAK2	NULL
,	NULL
implicating	NULL
these	NULL
kinases	NULL
in	NULL
the	NULL
early	NULL
signal-transduction	NULL
events	NULL
after	NULL
interaction	NULL
of	NULL
IL-12	NULL
with	NULL
its	NULL
receptor	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Many	NULL
cytokines	NULL
that	NULL
activate	NULL
JAK	NULL
kinases	NULL
induce	NULL
the	NULL
binding	NULL
of	NULL
STAT	NULL
proteins	NULL
to	NULL
a	NULL
series	NULL
of	NULL
palindromic	NULL
IFN-y-activation	NULL
site-related	NULL
DNA	NULL
oligonucleotides	NULL
with	NULL
the	NULL
consensus	NULL
sequence	NULL
TTNCNNNAA	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
by	NULL
EMSA	NULL
whether	NULL
IL-12	NULL
might	NULL
also	NULL
induce	NULL
such	NULL
DNA-binding	NULL
complexes	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
from	NULL
untreated	NULL
or	NULL
cytokine-treated	NULL
PHA-activated	NULL
T	NULL
cells	NULL
were	NULL
examined	NULL
for	NULL
binding	NULL
to	NULL
a	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
GRR	NULL
of	NULL
the	NULL
human	NULL
Foy	NULL
receptor	NULL
I	NULL
gene	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
a	NULL
number	NULL
of	NULL
cytokine-activated	NULL
nuclear	NULL
factors	NULL
(	NULL
14	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Extracts	NULL
from	NULL
untreated	NULL
PHA-stimulated	NULL
human	NULL
T	NULL
cells	NULL
contained	NULL
three	NULL
GRR-binding	NULL
complexes	NULL
designated	NULL
here	NULL
as	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
IL-12	NULL
induced	NULL
a	NULL
more	NULL
slowly	NULL
migrating	NULL
complex	NULL
,	NULL
which	NULL
we	NULL
have	NULL
called	NULL
IL-12-stimulated	NULL
factor	NULL
(	NULL
IL-12SF	NULL
)	NULL
,	NULL
which	NULL
appeared	NULL
within	NULL
5	NULL
min	NULL
of	NULL
stimulation	NULL
and	NULL
was	NULL
still	NULL
present	NULL
after	NULL
45	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
band	NULL
C	NULL
was	NULL
only	NULL
weakly	NULL
detectable	NULL
in	NULL
untreated	NULL
cells	NULL
and	NULL
was	NULL
modestly	NULL
enhanced	NULL
by	NULL
IL-12	NULL
treatment	NULL
.	NULL

However	NULL
,	NULL
this	NULL
was	NULL
not	NULL
a	NULL
consistent	NULL
finding	NULL
;	NULL
in	NULL
most	NULL
donors	NULL
band	NULL
C	NULL
was	NULL
detectable	NULL
in	NULL
untreated	NULL
cells	NULL
and	NULL
was	NULL
unaffected	NULL
by	NULL
treatment	NULL
with	NULL
IL-12	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
complex	NULL
C	NULL
to	NULL
the	NULL
IL-12	NULL
response	NULL
therefore	NULL
remains	NULL
unclear	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-12SF	NULL
was	NULL
not	NULL
None	NULL
_	NULL
GRR	NULL
_	NULL
ISRE	NULL
[	NULL
X	NULL
aia	NULL
``	NULL
=	NULL
)	NULL
a	NULL
3	NULL
%	NULL
3	NULL
S	NULL
30	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

(	NULL
4	NULL
)	NULL
IL-12	NULL
induces	NULL
a	NULL
2	NULL
E	NULL
a	NULL
E	NULL
a	NULL
&	NULL
DNA-binding	NULL
complex	NULL
(	NULL
IL-12SF	NULL
)	NULL
that	NULL
recognizes	NULL
the	NULL
GRR	NULL
of	NULL
the	NULL
FoyRI	NULL
gene	NULL
.	NULL

PHA-activated	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
with	NULL
IL-12	NULL
at	NULL
100	NULL
units/ml	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
,	NULL
with	NULL
IFN-a	NULL
at	NULL
500	NULL
units	NULL
/ml	NULL
for	NULL
15	NULL
min	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
or	NULL
with	NULL
IL-6	NULL
at	NULL
200	NULL
ng/ml	NULL
for	NULL
15	NULL
min	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
an	NULL
EMSA	NULL
was	NULL
done	NULL
using	NULL
the	NULL
GRR	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

CTL	NULL
,	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Competition	NULL
of	NULL
IL-12SF	NULL
using	NULL
unlabeled	NULL
oligonucleotides	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
PHA-activated	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-12	NULL
at	NULL
100	NULL
units/ml	NULL
$	NULL
!	NULL

.	NULL

(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
or	NULL
IFN-a	NULL
«	NULL
at	NULL
500	NULL
<	NULL
no	NULL
0	NULL
.	NULL

__	NULL
units/ml	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Competition	NULL
was	NULL
performed	NULL
by	NULL
incubat-_	NULL
ing	NULL
extracts	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
-	NULL
%	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
GRR	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
the	NULL
ISRE	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
before	NULL
addition	NULL
of	NULL
labeled	NULL
GRR	NULL
probe	NULL
and	NULL
electrophoresis	NULL
.	NULL

Immunology	NULL
:	NULL
Bacon	NULL
et	NULL
al	NULL
.	NULL

present	NULL
in	NULL
unstimulated	NULL
cells	NULL
from	NULL
any	NULL
of	NULL
the	NULL
donors	NULL
examined	NULL
and	NULL
was	NULL
induced	NULL
in	NULL
all	NULL
donors	NULL
by	NULL
IL-12	NULL
treatment	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
same	NULL
cells	NULL
with	NULL
either	NULL
IFN-a	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
IL-6	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
induced	NULL
a	NULL
complex	NULL
that	NULL
migrated	NULL
at	NULL
approximately	NULL
the	NULL
same	NULL
position	NULL
as	NULL
IL-12SF	NULL
.	NULL

IL-12SF	NULL
,	NULL
complexes	NULL
A-C	NULL
,	NULL
and	NULL
the	NULL
complexes	NULL
induced	NULL
by	NULL
IFN-a	NULL
and	NULL
IL-6	NULL
each	NULL
bound	NULL
specifically	NULL
to	NULL
the	NULL
labeled	NULL
GRR	NULL
sequence	NULL
.	NULL

These	NULL
complexes	NULL
could	NULL
be	NULL
displaced	NULL
by	NULL
competition	NULL
with	NULL
unlabeled	NULL
GRR	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
but	NULL
not	NULL
with	NULL
an	NULL
unlabeled	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
ISRE	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
or	NULL
with	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
DNA-binding	NULL
site	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
STAT	NULL
proteins	NULL
to	NULL
bind	NULL
to	NULL
target	NULL
DNA	NULL
elements	NULL
depends	NULL
upon	NULL
their	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
14	NULL
,	NULL
34	NULL
)	NULL
,	NULL
and	NULL
tyrosine-phosphorylated	NULL
STAT1	NULL
binds	NULL
to	NULL
GRR	NULL
in	NULL
response	NULL
to	NULL
IFN-y	NULL
and	NULL
other	NULL
cytokines	NULL
(	NULL
14	NULL
,	NULL
30	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
IL-12	NULL
could	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
or	NULL
STAT2	NULL
,	NULL
which	NULL
might	NULL
be	NULL
components	NULL
of	NULL
IL-12SF	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
lysates	NULL
from	NULL
untreated	NULL
or	NULL
cytokine-treated	NULL
PHA-activated	NULL
T	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antiserum	NULL
to	NULL
STAT1	NULL
or	NULL
STAT2	NULL
,	NULL
resolved	NULL
by	NULL
SDS/PAGE	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
anti-phosphotyrosine	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Upper	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
IFN-a	NULL
«	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
STAT1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
STAT2	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

In	NULL
response	NULL
to	NULL
IFN-a	NULL
,	NULL
STAT1	NULL
and	NULL
STAT2	NULL
associate	NULL
in	NULL
a	NULL
transcriptional	NULL
complex	NULL
known	NULL
as	NULL
interferon-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Con-sequently	NULL
,	NULL
the	NULL
anti-STAT2	NULL
antiserum	NULL
used	NULL
was	NULL
able	NULL
to	NULL
coim-munoprecipitate	NULL
tyrosine-phosphorylated	NULL
STAT	NULL
1	NULL
from	NULL
IFNa-treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
as	NULL
described	NULL
(	NULL
17	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
IFN-a	NULL
,	NULL
IL-12	NULL
treatment	NULL
caused	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
neither	NULL
STAT1	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
nor	NULL
STAT2	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
equal	NULL
levels	NULL
of	NULL
STAT1	NULL
and	NULL
STAT2	NULL
in	NULL
each	NULL
lane	NULL
was	NULL
demonstrated	NULL
by	NULL
stripping	NULL
these	NULL
blots	NULL
and	NULL
reprobing	NULL
with	NULL
antiserum	NULL
against	NULL
STAT1	NULL
and	NULL
STAT2	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Lower	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
STAT1	NULL
and	NULL
STAT2	NULL
are	NULL
not	NULL
activated	NULL
by	NULL
IL-12	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
are	NULL
unlikely	NULL
to	NULL
be	NULL
components	NULL
of	NULL
the	NULL
IL-12SF	NULL
complex	NULL
.	NULL

STAT4	NULL
is	NULL
a	NULL
recently	NULL
identified	NULL
STAT	NULL
family	NULL
member	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
tissues	NULL
,	NULL
including	NULL
thymus	NULL
and	NULL
spleen	NULL
,	NULL
but	NULL
not	NULL
in	NULL
a	NULL
number	NULL
of	NULL
murine	NULL
T	NULL
cell	NULL
lines	NULL
tested	NULL
or	NULL
in	NULL
many	NULL
other	NULL
tissues	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
STAT4	NULL
could	NULL
potentially	NULL
be	NULL
a	NULL
component	NULL
of	NULL
the	NULL
IL-12-induced	NULL
GRR-binding	NULL
complex	NULL
(	NULL
IL-12SF	NULL
)	NULL
,	NULL
we	NULL
first	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
its	NULL
expression	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Fresh	NULL
peripheral	NULL
T	NULL
cells	NULL
from	NULL
a	NULL
number	NULL
of	NULL
donors	NULL
expressed	NULL
either	NULL
low	NULL
or	NULL
undetectable	NULL
levels	NULL
of	NULL
STAT4	NULL
protein	NULL
by	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
T	NULL
cells	NULL
only	NULL
express	NULL
IL-12R	NULL
and	NULL
respond	NULL
functionally	NULL
to	NULL
IL-12	NULL
after	NULL
activation	NULL
with	NULL
agents	NULL
such	NULL
as	NULL
PHA	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
components	NULL
of	NULL
other	NULL
cytokine	NULL
signaling	NULL
pathways	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
and	NULL
JAK	NULL
3	NULL
,	NULL
are	NULL
strongly	NULL
up-regulated	NULL
by	NULL
T-cell	NULL
activation	NULL
(	NULL
9	NULL
,	NULL
36	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
STAT4	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
for	NULL
various	NULL
times	NULL
with	NULL
PHA	NULL
.	NULL

PHA	NULL
induced	NULL
expression	NULL
of	NULL
STAT4	NULL
protein	NULL
in	NULL
a	NULL
time-dependent	NULL
manner	NULL
;	NULL
maximal	NULL
induction	NULL
was	NULL
observed	NULL
after	NULL
72	NULL
hr	NULL
of	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
time	NULL
course	NULL
of	NULL
STAT4	NULL
expression	NULL
mirrors	NULL
closely	NULL
the	NULL
kinetics	NULL
of	NULL
induction	NULL
of	NULL
IL-12R	NULL
expression	NULL
on	NULL
T	NULL
cells	NULL
by	NULL
PHA	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
acquisition	NULL
of	NULL
IL-12	NULL
responsiveness	NULL
(	NULL
35	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
STAT4	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
IL-12	NULL
signal	NULL
transduction	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
STAT4	NULL
was	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
other	NULL
IL-12-responsive	NULL
cells	NULL
:	NULL
fresh	NULL
peripheral	NULL
NK	NULL
cells	NULL
,	NULL
Kit	NULL
225/K6	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
NK3.3	NULL
cell	NULL
line	NULL
(	NULL
37	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
fresh	NULL
tonsillar	NULL
B	NULL
cells	NULL
and	NULL
the	NULL
NK-like	NULL
cell	NULL
line	NULL
YT	NULL
,	NULL
which	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
IL-12	NULL
,	NULL
did	NULL
not	NULL
express	NULL
STAT4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
suggested	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
STAT4	NULL
in	NULL
IL-12	NULL
signal	NULL
transduction	NULL
.	NULL

To	NULL
more	NULL
directly	NULL
establish	NULL
a	NULL
role	NULL
for	NULL
STAT4	NULL
in	NULL
IL-12	NULL
signaling	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
IL-12	NULL
to	NULL
stimulate	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT4	NULL
was	NULL
assessed	NULL
.	NULL

STAT4	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
cytokine-treated	NULL
or	NULL
-untreated	NULL
IL-12-responsive	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
_	NULL
7309	NULL
A	NULL
wh	NULL
anti-P	NULL
-Tyr	NULL
ip	NULL
:	NULL
anti-STAT1	NULL
anti-STAT2	NULL
2	NULL
3	NULL
33	NULL
52	NULL
#	NULL
3	NULL
5	NULL
3	NULL
&	NULL
5	NULL
3	NULL
&	NULL
woes	NULL
<	NULL
-	NULL
STAT2	NULL
wre	NULL
magi—STATHx	NULL
wh	NULL
:	NULL
anti-STAT1	NULL
anti-STAT2	NULL
STATia-	NULL
»	NULL
SstaAtip~	NULL
»	NULL
>	NULL
``	NULL
``	NULL
Te	NULL
4	NULL
5006	NULL
B	NULL
_	NULL
Biot	NULL
:	NULL
Anti-STAT4	NULL
rre	NULL
e	NULL
n	NULL
Hrs	NULL
:	NULL
0	NULL
3	NULL
12	NULL
24	NULL
48	NULL
72	NULL
97	NULL
cuss	NULL
.	NULL

emmm	NULL
69	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

(	NULL
4	NULL
)	NULL
IL-12	NULL
does	NULL
not	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
or	NULL
STAT2	NULL
.	NULL

PHA-activated	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
,	NULL
with	NULL
IL-12	NULL
at	NULL
100	NULL
units/ml	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
with	NULL
IFN-a	NULL
at	NULL
1000	NULL
units/ml	NULL
(	NULL
lanes	NULL
3-6	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
ip	NULL
)	NULL
with	NULL
anti-STAT1	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
or	NULL
anti-STAT2	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
antiserum	NULL
,	NULL
resolved	NULL
by	NULL
SDS/PAGE	NULL
,	NULL
transferred	NULL
to	NULL
Immobilon	NULL
,	NULL
and	NULL
blotted	NULL
sequentially	NULL
with	NULL
anti-phosphotyrosine	NULL
(	NULL
Up-per	NULL
)	NULL
,	NULL
and	NULL
anti-STAT1	NULL
or	NULL
anti-STAT2	NULL
(	NULL
Lower	NULL
)	NULL
.	NULL

wh	NULL
,	NULL
Western	NULL
blot	NULL
.	NULL

(	NULL
B	NULL
)	NULL
PHA	NULL
induces	NULL
STAT4	NULL
expression	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
PHA	NULL
at	NULL
2	NULL
ug/ml	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
made	NULL
.	NULL

Lysates	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
SDS/PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-STAT4	NULL
antiserum	NULL
.	NULL

cells	NULL
and	NULL
analyzed	NULL
by	NULL
anti-phosphotyrosine	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
Upper	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
PHA-activated	NULL
T	NULL
cells	NULL
with	NULL
IL-12	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
induced	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT4	NULL
.	NULL

Phosphorylation	NULL
of	NULL
STAT4	NULL
could	NULL
be	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
5	NULL
min	NULL
and	NULL
was	NULL
maintained	NULL
for	NULL
>	NULL
30	NULL
min	NULL
.	NULL

Neither	NULL
IL-2	NULL
(	NULL
Jane	NULL
5	NULL
)	NULL
,	NULL
which	NULL
shares	NULL
many	NULL
functional	NULL
effects	NULL
with	NULL
IL-12	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
,	NULL
nor	NULL
IL-4	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
stimulated	NULL
STAT4	NULL
phosphorylation	NULL
.	NULL

Equal	NULL
loading	NULL
of	NULL
STAT4	NULL
was	NULL
demonstrated	NULL
by	NULL
reprobing	NULL
the	NULL
membrane	NULL
with	NULL
an	NULL
antiserum	NULL
against	NULL
STAT4	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
Lower	NULL
)	NULL
.	NULL

Addition-ally	NULL
,	NULL
IL-12	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT4	NULL
in	NULL
Kit225/K6	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
whereas	NULL
no	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
were	NULL
detected	NULL
in	NULL
immunoprecipitates	NULL
using	NULL
a	NULL
control	NULL
rabbit	NULL
anti-serum	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
both	NULL
fresh	NULL
peripheral	NULL
NK	NULL
cells	NULL
and	NULL
the	NULL
NK	NULL
cell	NULL
line	NULL
NK3.3	NULL
with	NULL
IL-12	NULL
also	NULL
stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
IL-12	NULL
treatment	NULL
consistently	NULL
induced	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
mobility	NULL
of	NULL
STAT4	NULL
protein	NULL
upon	NULL
SDS/PAGE	NULL
,	NULL
from	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
~90	NULL
kDa	NULL
to	NULL
an	NULL
apparent	NULL
mass	NULL
of	NULL
~95	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
4	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
appearance	NULL
of	NULL
this	NULL
95-kDa	NULL
species	NULL
differed	NULL
markedly	NULL
from	NULL
the	NULL
time	NULL
course	NULL
of	NULL
STAT4	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
as	NULL
detected	NULL
by	NULL
antibody	NULL
7310	NULL
_	NULL
Immunology	NULL
:	NULL
Bacon	NULL
et	NULL
al	NULL
.	NULL

A	NULL
Blot	NULL
:	NULL
Anti-P-Tyr	NULL
or	NULL
nmr	NULL
cy	NULL
CTL	NULL
IL-12	NULL
IL-2	NULL
IL-4	NULL
B	NULL
Min	NULL
:	NULL
0	NULL
5	NULL
15	NULL
30	NULL
1	NULL
P	NULL
:	NULL
Anti-STAT4	NULL
CTL	NULL
fener	NULL
200	NULL
-	NULL
C	NULL
IL-12	NULL
C	NULL
IL-12	NULL
Min	NULL
:	NULL
0	NULL
5	NULL
30	NULL
0	NULL
5	NULL
97	NULL
-	NULL
(	NULL
ee	NULL
200-sae	NULL
a	NULL
69	NULL
-	NULL
|	NULL
97-	NULL
|	NULL
--	NULL
69-	NULL
Blot	NULL
:	NULL
Anti-STAT4	NULL
46	NULL
-	NULL
I	NULL
pee	NULL
ooo	NULL
aas	NULL
a	NULL
oem	NULL
97	NULL
-	NULL
some	NULL
cmmp	NULL
UB	NULL
**	NULL
``	NULL
ao	NULL
«	NULL
-69	NULL
1	NULL
20	NULL
3	NULL
40	NULL
50	NULL
6	NULL
1°2	NULL
3	NULL
°40	NULL
5	NULL
C	NULL
IL-12	NULL
SF-	NULL
»	NULL
1	NULL
2	NULL
.	NULL

B00	NULL
4	NULL
FiG	NULL
.	NULL

3	NULL
.	NULL

(	NULL
4	NULL
)	NULL
IL-12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT4	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
PHA-activated	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
%	NULL
107	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
with	NULL
IL-12	NULL
at	NULL
100	NULL
units/ml	NULL
!	NULL

for	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
,	NULL
with	NULL
IL-2	NULL
at	NULL
1000	NULL
units/ml	NULL
for	NULL
15	NULL
min	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
or	NULL
with	NULL
IL-4	NULL
at	NULL
1000	NULL
units/ml	NULL
for	NULL
15	NULL
min	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-STAT4	NULL
antiserum	NULL
,	NULL
resolved	NULL
by	NULL
SDS/PAGE	NULL
,	NULL
transferred	NULL
to	NULL
Immobilon	NULL
,	NULL
and	NULL
blotted	NULL
sequentially	NULL
with	NULL
anti-phosphotyrosine	NULL
(	NULL
Anti-P-Tyr	NULL
)	NULL
(	NULL
Upper	NULL
)	NULL
and	NULL
anti-STAT4	NULL
(	NULL
Lower	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
IL-12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATA	NULL
in	NULL
Kit	NULL
225/K6	NULL
cells	NULL
.	NULL

Kit	NULL
225/K6	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
or	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
IL-12	NULL
at	NULL
100	NULL
units/ml	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-STAT4	NULL
antiserum	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
or	NULL
with	NULL
a	NULL
control	NULL
antiserum	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
resolved	NULL
by	NULL
SDS/PAGE	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
anti-phosphotyrosine	NULL
immunoblotting	NULL
.	NULL

(	NULL
C	NULL
)	NULL
IL-12SF	NULL
contains	NULL
STAT4	NULL
.	NULL

PHA-activated	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
IL-12	NULL
at	NULL
100	NULL
units/ml	NULL
for	NULL
15	NULL
min	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
an	NULL
EMSA	NULL
was	NULL
done	NULL
with	NULL
the	NULL
GRR	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Antiserum	NULL
against	NULL
STAT4	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
a	NULL
control	NULL
antiserum	NULL
(	NULL
C	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
cell	NULL
extracts	NULL
for	NULL
60	NULL
min	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

IP	NULL
,	NULL
immunoprecipitation	NULL
;	NULL
CTL	NULL
,	NULL
control	NULL
.	NULL

4G10	NULL
immunoblotting	NULL
)	NULL
.	NULL

Although	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT4	NULL
was	NULL
already	NULL
maximal	NULL
at	NULL
5	NULL
min	NULL
of	NULL
stimulation	NULL
,	NULL
only	NULL
a	NULL
small	NULL
fraction	NULL
,	NULL
if	NULL
any	NULL
,	NULL
of	NULL
the	NULL
STAT4	NULL
migrated	NULL
in	NULL
the	NULL
upper	NULL
band	NULL
at	NULL
this	NULL
time	NULL
.	NULL

At	NULL
15-20	NULL
min	NULL
approximately	NULL
half	NULL
of	NULL
the	NULL
STAT4	NULL
protein	NULL
ran	NULL
at	NULL
the	NULL
higher	NULL
apparent	NULL
weight	NULL
,	NULL
and	NULL
at	NULL
30-45	NULL
min	NULL
of	NULL
stimulation	NULL
most	NULL
,	NULL
if	NULL
not	NULL
all	NULL
,	NULL
STAT4	NULL
detectable	NULL
by	NULL
anti-phosphotyrosine	NULL
or	NULL
anti-STAT4	NULL
immunoblotting	NULL
migrated	NULL
in	NULL
the	NULL
upper	NULL
band	NULL
.	NULL

Notably	NULL
,	NULL
a	NULL
cytokine-induced	NULL
decrease	NULL
in	NULL
migration	NULL
through	NULL
SDS/PAGE	NULL
gels	NULL
has	NULL
also	NULL
been	NULL
observed	NULL
for	NULL
STAT1	NULL
(	NULL
15	NULL
,	NULL
38	NULL
)	NULL
and	NULL
STAT3	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
kinases	NULL
p56	NULL
``	NULL
and	NULL
c-raf	NULL
exhibit	NULL
a	NULL
similar	NULL
decrease	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
after	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
this	NULL
effect	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
the	NULL
result	NULL
of	NULL
serine/threonine	NULL
phosphorylation	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Recently	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
STAT	NULL
proteins	NULL
(	NULL
39	NULL
,	NULL
42	NULL
)	NULL
,	NULL
like	NULL
a	NULL
number	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
43	NULL
)	NULL
,	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
serine/threonine	NULL
phosphorylation	NULL
,	NULL
and	NULL
it	NULL
is	NULL
intriguing	NULL
to	NULL
consider	NULL
that	NULL
phosphorylation	NULL
of	NULL
serine/	NULL
threonine	NULL
as	NULL
well	NULL
as	NULL
tyrosine	NULL
residues	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
STAT4	NULL
function	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT4	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
suggests	NULL
that	NULL
the	NULL
IL-12SF	NULL
detected	NULL
by	NULL
EMSA	NULL
might	NULL
contain	NULL
STAT4	NULL
.	NULL

To	NULL
test	NULL
this	NULL
directly	NULL
,	NULL
EMSAs	NULL
were	NULL
done	NULL
in	NULL
which	NULL
antibodies	NULL
to	NULL
STAT4	NULL
or	NULL
control	NULL
antibodies	NULL
were	NULL
included	NULL
in	NULL
the	NULL
DNA-binding	NULL
reaction	NULL
before	NULL
addition	NULL
of	NULL
P-labeled	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Antiserum	NULL
to	NULL
STAT4	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
but	NULL
not	NULL
a	NULL
control	NULL
antiserum	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
was	NULL
able	NULL
to	NULL
supershift	NULL
the	NULL
IL-12SF	NULL
complex	NULL
,	NULL
indicating	NULL
that	NULL
IL-12SF	NULL
contained	NULL
STAT4	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
and	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
antiserum	NULL
to	NULL
STAT1	NULL
supershifted	NULL
the	NULL
IFN-	NULL
«	NULL
-induced	NULL
GRR-binding	NULL
complex	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
IL-12SF	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Antiserum	NULL
to	NULL
STAT4	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
constitutive	NULL
GRR-binding	NULL
complexes	NULL
A-C	NULL
or	NULL
on	NULL
the	NULL
complexes	NULL
induced	NULL
by	NULL
either	NULL
IL-6	NULL
or	NULL
IFN-a	NULL
«	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
do	NULL
not	NULL
contain	NULL
STAT4	NULL
and	NULL
are	NULL
therefore	NULL
different	NULL
in	NULL
composition	NULL
from	NULL
IL-12SF	NULL
.	NULL

However	NULL
,	NULL
although	NULL
IL-12	NULL
is	NULL
the	NULL
only	NULL
reported	NULL
inducer	NULL
of	NULL
STAT4	NULL
activation	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
STAT4	NULL
in	NULL
myeloid	NULL
cells	NULL
and	NULL
in	NULL
developing	NULL
spermatogonia	NULL
(	NULL
24	NULL
)	NULL
suggests	NULL
that	NULL
other	NULL
STAT4	NULL
activating	NULL
ligands	NULL
might	NULL
exist	NULL
.	NULL

A	NULL
number	NULL
of	NULL
cytokines	NULL
that	NULL
signal	NULL
via	NULL
JAK	NULL
kinases	NULL
have	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
activation	NULL
of	NULL
STATs	NULL
(	NULL
8	NULL
,	NULL
13-15	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
JAK-deficient	NULL
cell	NULL
lines	NULL
has	NULL
shown	NULL
that	NULL
JAK	NULL
kinases	NULL
are	NULL
necessary	NULL
for	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT2	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
,	NULL
and	NULL
over-expression	NULL
of	NULL
JAKs	NULL
can	NULL
activate	NULL
STAT	NULL
DNA-binding	NULL
activity	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Data	NULL
such	NULL
as	NULL
these	NULL
suggest	NULL
that	NULL
JAK	NULL
kinases	NULL
might	NULL
directly	NULL
regulate	NULL
STAT	NULL
proteins	NULL
,	NULL
and	NULL
the	NULL
``	NULL
JAK-STAT	NULL
``	NULL
pathway	NULL
has	NULL
been	NULL
proposed	NULL
as	NULL
a	NULL
paradigm	NULL
for	NULL
cytokine	NULL
signaling	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
IL-12	NULL
stimulation	NULL
of	NULL
human	NULL
lymphocytes	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT4	NULL
but	NULL
not	NULL
of	NULL
STAT1	NULL
or	NULL
STAT2	NULL
.	NULL

Moreover	NULL
,	NULL
IL-12	NULL
stimulates	NULL
the	NULL
formation	NULL
of	NULL
nuclear	NULL
complexes	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
GRR	NULL
DNA	NULL
sequence	NULL
,	NULL
and	NULL
these	NULL
complexes	NULL
contain	NULL
STAT4	NULL
.	NULL

Together	NULL
with	NULL
our	NULL
previous	NULL
finding	NULL
that	NULL
IL-12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
and	NULL
Tyk2	NULL
(	NULL
6	NULL
)	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
a	NULL
specific	NULL
JAK-STAT	NULL
pathway	NULL
may	NULL
transduce	NULL
rapid	NULL
and	NULL
direct	NULL
IL-12	NULL
signals	NULL
to	NULL
the	NULL
nuclei	NULL
of	NULL
responsive	NULL
cells	NULL
and	NULL
provide	NULL
a	NULL
clear	NULL
basis	NULL
for	NULL
understanding	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
IL-12	NULL
might	NULL
regulate	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
mechanisms	NULL
controlling	NULL
the	NULL
induction	NULL
of	NULL
genes	NULL
such	NULL
as	NULL
IFN-y	NULL
and	NULL
perforin	NULL
by	NULL
IL-12	NULL
are	NULL
still	NULL
very	NULL
poorly	NULL
characterized	NULL
,	NULL
and	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
analyze	NULL
the	NULL
function	NULL
of	NULL
STAT4	NULL
in	NULL
these	NULL
responses	NULL
.	NULL

Some	NULL
cytokines	NULL
,	NULL
including	NULL
IL-6	NULL
and	NULL
epidermal	NULL
growth	NULL
factor	NULL
,	NULL
promote	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
more	NULL
than	NULL
one	NULL
STAT	NULL
protein	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Epidermal	NULL
growth	NULL
factor	NULL
,	NULL
for	NULL
example	NULL
,	NULL
causes	NULL
activation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
,	NULL
which	NULL
can	NULL
bind	NULL
DNA	NULL
as	NULL
either	NULL
homo-	NULL
or	NULL
heterodimers	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Whether	NULL
STAT4	NULL
forms	NULL
homo-	NULL
or	NULL
heterodimers	NULL
upon	NULL
activation	NULL
by	NULL
IL-12	NULL
is	NULL
unclear	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
STAT1	NULL
and	NULL
STAT2	NULL
are	NULL
not	NULL
phosphorylated	NULL
or	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
but	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
that	NULL
other	NULL
STAT	NULL
family	NULL
members	NULL
(	NULL
or	NULL
unrelated	NULL
proteins	NULL
)	NULL
might	NULL
also	NULL
be	NULL
components	NULL
of	NULL
IL-12SF	NULL
or	NULL
that	NULL
IL-12	NULL
might	NULL
induce	NULL
binding	NULL
of	NULL
distinct	NULL
STATs	NULL
to	NULL
other	NULL
DNA	NULL
sequences	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
preliminary	NULL
data	NULL
suggest	NULL
that	NULL
in	NULL
some	NULL
cell	NULL
types	NULL
,	NULL
IL-12	NULL
can	NULL
also	NULL
stimulate	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
level	NULL
of	NULL
STAT3	NULL
phosphorylation	NULL
detected	NULL
is	NULL
minimal	NULL
in	NULL
comparison	NULL
with	NULL
that	NULL
induced	NULL
by	NULL
IL-6	NULL
and	NULL
IFN-a	NULL
,	NULL
and	NULL
the	NULL
significance	NULL
of	NULL
this	NULL
finding	NULL
is	NULL
as	NULL
yet	NULL
unclear	NULL
.	NULL

Little	NULL
STAT4	NULL
is	NULL
expressed	NULL
in	NULL
resting	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
negligible	NULL
surface	NULL
levels	NULL
of	NULL
IL-12R	NULL
(	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
STAT4	NULL
protein	NULL
levels	NULL
are	NULL
increased	NULL
dramatically	NULL
upon	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
PHA	NULL
with	NULL
a	NULL
time	NULL
course	NULL
similar	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
IL-12R	NULL
expression	NULL
and	NULL
the	NULL
acquisition	NULL
of	NULL
IL-12	NULL
responsiveness	NULL
(	NULL
35	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
pattern	NULL
of	NULL
expression	NULL
has	NULL
been	NULL
Immunology	NULL
:	NULL
Bacon	NULL
et	NULL
a/	NULL
.	NULL

previously	NULL
described	NULL
for	NULL
components	NULL
of	NULL
the	NULL
IL-2	NULL
signaling	NULL
path-way	NULL
,	NULL
in	NULL
which	NULL
both	NULL
IL-2Ra	NULL
and	NULL
JAK3	NULL
are	NULL
induced	NULL
in	NULL
T	NULL
cells	NULL
with	NULL
a	NULL
time	NULL
course	NULL
parallel	NULL
to	NULL
that	NULL
of	NULL
IL-2	NULL
responsiveness	NULL
(	NULL
9	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
components	NULL
of	NULL
cytokine	NULL
signaling	NULL
complexes	NULL
can	NULL
be	NULL
coordinately	NULL
regulated	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
such	NULL
coregulation	NULL
of	NULL
signaling	NULL
molecules	NULL
is	NULL
one	NULL
mechanism	NULL
by	NULL
which	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
control	NULL
cytokine	NULL
responsiveness	NULL
during	NULL
the	NULL
inflammatory	NULL
immune	NULL
response	NULL
.	NULL

IL-2	NULL
and	NULL
IL-12	NULL
exert	NULL
many	NULL
similar	NULL
biological	NULL
effects	NULL
on	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
including	NULL
the	NULL
induction	NULL
of	NULL
common	NULL
genes	NULL
such	NULL
as	NULL
IFN-y	NULL
and	NULL
perforin	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
this	NULL
similarity	NULL
are	NULL
unclear	NULL
.	NULL

Although	NULL
JAK2	NULL
and	NULL
Tyk2	NULL
are	NULL
implicated	NULL
in	NULL
IL-12	NULL
responses	NULL
(	NULL
6	NULL
)	NULL
,	NULL
IL-2	NULL
stimulates	NULL
the	NULL
activation	NULL
of	NULL
JAK1	NULL
and	NULL
JAK3	NULL
(	NULL
10	NULL
,	NULL
11	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
while	NULL
IL-12	NULL
,	NULL
but	NULL
not	NULL
IL-2	NULL
,	NULL
triggers	NULL
activation	NULL
of	NULL
STAT4	NULL
,	NULL
IL-2	NULL
activates	NULL
distinct	NULL
STATs	NULL
(	NULL
48	NULL
)	NULL
which	NULL
we	NULL
and	NULL
others	NULL
have	NULL
recently	NULL
identified	NULL
as	NULL
STAT3	NULL
and	NULL
STATS	NULL
(	NULL
49-51	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
although	NULL
IL-12	NULL
and	NULL
IFNs	NULL
a	NULL
and	NULL
y	NULL
have	NULL
many	NULL
similar	NULL
effects	NULL
on	NULL
lymphocytes	NULL
,	NULL
these	NULL
cytokines	NULL
differ	NULL
biochemically	NULL
in	NULL
that	NULL
the	NULL
IFNs	NULL
,	NULL
but	NULL
not	NULL
IL-12	NULL
,	NULL
activate	NULL
STAT1	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
different	NULL
JAKs	NULL
and	NULL
STAT	NULL
's	NULL
by	NULL
these	NULL
cytokines	NULL
is	NULL
dictated	NULL
by	NULL
the	NULL
differential	NULL
ability	NULL
of	NULL
these	NULL
molecules	NULL
to	NULL
bind	NULL
to	NULL
each	NULL
cytokine	NULL
's	NULL
receptor	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Further	NULL
investigation	NULL
of	NULL
the	NULL
ways	NULL
in	NULL
which	NULL
distinct	NULL
signaling	NULL
pathways	NULL
such	NULL
as	NULL
these	NULL
converge	NULL
to	NULL
produce	NULL
common	NULL
effects	NULL
should	NULL
lead	NULL
to	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
cytokines	NULL
control	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

We	NULL
thank	NULL
William	NULL
Bere	NULL
and	NULL
Anna	NULL
Mason	NULL
for	NULL
preparation	NULL
of	NULL
human	NULL
lymphocyte	NULL
populations	NULL
,	NULL
Dr.	NULL
J.	NULL
Kornbluth	NULL
(	NULL
Arkansas	NULL
Cancer	NULL
Research	NULL
Center	NULL
)	NULL
for	NULL
kindly	NULL
providing	NULL
the	NULL
NK3.3	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
Dr.	NULL
Stanley	NULL
Wolf	NULL
(	NULL
Genetics	NULL
Institute	NULL
)	NULL
for	NULL
generously	NULL
providing	NULL
IL-12	NULL
.	NULL

We	NULL
are	NULL
also	NULL
grateful	NULL
to	NULL
Drs	NULL
.	NULL

Eda	NULL
Bloom	NULL
and	NULL
Daniel	NULL
McVicar	NULL
for	NULL
their	NULL
critical	NULL
review	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

C.M.B	NULL
.	NULL

received	NULL
a	NULL
Ph.D.	NULL
Student	NULL
Research	NULL
Grant	NULL
from	NULL
the	NULL
University	NULL
of	NULL
Sheffield	NULL
,	NULL
U.K.	NULL
,	NULL
and	NULL
is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
U.S.-U.K.	NULL
Education	NULL
Commission	NULL
(	NULL
Fulbright	NULL
Commission	NULL
)	NULL
Cancer	NULL
Studentship	NULL
;	NULL
C.M.B	NULL
.	NULL

and	NULL
R.C.R	NULL
.	NULL

are	NULL
supported	NULL
by	NULL
the	NULL
Yorkshire	NULL
Cancer	NULL
Research	NULL
Campaign	NULL
(	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

1	NULL
.	NULL

D'Andrea	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Rengaraju	NULL
,	NULL
M.	NULL
,	NULL
Valiante	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
Chehimi	NULL
,	NULL
J.	NULL
,	NULL
Kubin	NULL
,	NULL
M.	NULL
,	NULL
Aste	NULL
,	NULL
M.	NULL
,	NULL
Chan	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Kobayashi	NULL
,	NULL
M.	NULL
,	NULL
Young	NULL
,	NULL
D.	NULL
,	NULL
Nickbarg	NULL
,	NULL
E.	NULL
,	NULL
Chizzonite	NULL
,	NULL
R.	NULL
,	NULL
Wolf	NULL
,	NULL
S.	NULL
F.	NULL
&	NULL
Trinchieri	NULL
,	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176	NULL
,	NULL
1387-1398	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Gazzinelli	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
Hieny	NULL
,	NULL
S.	NULL
,	NULL
Wynn	NULL
,	NULL
T.	NULL
,	NULL
Wolf	NULL
,	NULL
S.	NULL
&	NULL
Sher	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
6115-6119	NULL
.	NULL

Trinchieri	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
4008-4027	NULL
.	NULL

Chehimi	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Trinchieri	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

14	NULL
,	NULL
149-161	NULL
.	NULL

Chua	NULL
,	NULL
A.	NULL
O.	NULL
,	NULL
Chizzonite	NULL
,	NULL
R.	NULL
,	NULL
Desai	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Truitt	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
Nunes	NULL
,	NULL
P.	NULL
,	NULL
Minetti	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Warrier	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Presky	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Levine	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Gately	NULL
,	NULL
M.	NULL
K.	NULL
&	NULL
Gubler	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

153	NULL
,	NULL
128-136	NULL
.	NULL

6	NULL
.	NULL

Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Rees	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

&	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
,	NULL
399-404	NULL
.	NULL

7	NULL
.	NULL

Pignata	NULL
,	NULL
C.	NULL
,	NULL
Sanghera	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Cossette	NULL
,	NULL
L.	NULL
,	NULL
Pelech	NULL
,	NULL
S.	NULL
L.	NULL
&	NULL
Ritz	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
184-190	NULL
.	NULL

8	NULL
.	NULL

-	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Yamamoto	NULL
,	NULL
K.	NULL
,	NULL
Thierfelder	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Krieder	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Silvennoinen	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

19	NULL
,	NULL
222-227	NULL
.	NULL

9.	NULL
.	NULL

Kawamura	NULL
,	NULL
M.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Blake	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
Chen	NULL
,	NULL
Y.	NULL
Q.	NULL
,	NULL
Lal	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Lloyd	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Kelvin	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Staples	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
&	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
,	NULL
6374-6378	NULL
.	NULL

10	NULL
.	NULL

Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Kawamura	NULL
,	NULL
M.	NULL
,	NULL
Kirken	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
Y.-C.	NULL
,	NULL
Blake	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
Shibuya	NULL
,	NULL
K.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
W.	NULL
&	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
370	NULL
,	NULL
151-153	NULL
.	NULL

11	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Kawamura	NULL
,	NULL
M.	NULL
,	NULL
Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Friedman	NULL
,	NULL
M.	NULL
,	NULL
Berg	NULL
,	NULL
M.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Sitvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Goldman	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Schmalsteig	NULL
,	NULL
F.C	NULL
.	NULL

,	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

&	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
266	NULL
,	NULL
1042-1044	NULL
.	NULL

12	NULL
.	NULL

Witthuhn	NULL
,	NULL
B.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Yi	NULL
,	NULL
T.	NULL
,	NULL
Tang	NULL
,	NULL
B.	NULL
,	NULL
Miura	NULL
,	NULL
O	NULL
.	NULL

&	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
74	NULL
,	NULL
227-236	NULL
.	NULL

13	NULL
.	NULL

Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
&	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
1415-1421	NULL
.	NULL

14	NULL
.	NULL

Larner	NULL
,	NULL
A.C.	NULL
,	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
Feldman	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Igarashi	NULL
,	NULL
K.	NULL
,	NULL
Hackett	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Webb	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Sweitzer	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
III	NULL
,	NULL
&	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1730-1733	NULL
.	NULL

15	NULL
.	NULL

Sadowski	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Gilman	NULL
,	NULL
M.	NULL
Z	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1739-1744	NULL
.	NULL

16	NULL
.	NULL

Kessler	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Veals	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Fu	NULL
,	NULL
X.-Y	NULL
.	NULL

&	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1753-1765.	NULL
in	NULL
p	NULL
u	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
7311	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Prezioso	NULL
,	NULL
V.	NULL
R.	NULL
&	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
809-815	NULL
.	NULL

Decker	NULL
,	NULL
T.	NULL
,	NULL
Lew	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Mirkovitch	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
927-932	NULL
.	NULL

Feldman	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
III	NULL
,	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
Larner	NULL
,	NULL
A.C.	NULL
&	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
10747-10752	NULL
.	NULL

Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Wen	NULL
,	NULL
Z	NULL
.	NULL

&	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
95-98	NULL
.	NULL

David	NULL
,	NULL
M.	NULL
,	NULL
Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
III	NULL
,	NULL
Igarashi	NULL
,	NULL
K.	NULL
,	NULL
Feldman	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
&	NULL
Larner	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
,	NULL
7174-7178	NULL
.	NULL

Wakao	NULL
,	NULL
H.	NULL
,	NULL
Gouilleux	NULL
,	NULL
F.	NULL
&	NULL
Groner	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
2182-2191	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Ho	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Brasseur	NULL
,	NULL
M.	NULL
&	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
1701-1706	NULL
.	NULL

Yamamoto	NULL
,	NULL
K.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Theirfelder	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Kreider	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Gilbert	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O	NULL
.	NULL

&	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
4342-4349	NULL
.	NULL

Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Wen	NULL
,	NULL
Z	NULL
.	NULL

&	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
,	NULL
4806-4810	NULL
.	NULL

Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Mason	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Overton	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

164	NULL
,	NULL
1193-1205	NULL
.	NULL

Stern	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Podlaski	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Hulmes	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Pan	NULL
,	NULL
Y.-C.	NULL
E.	NULL
,	NULL
Quinn	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Wolitzky	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Familletti	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Stremlo	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Truitt	NULL
,	NULL
T.	NULL
,	NULL
Chizzonite	NULL
,	NULL
R.	NULL
&	NULL
Gately	NULL
,	NULL
M.	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
6808-6812	NULL
.	NULL

Desai	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
Truitt	NULL
,	NULL
T.	NULL
,	NULL
Honasoge	NULL
,	NULL
S.	NULL
,	NULL
Warrier	NULL
,	NULL
R.	NULL
,	NULL
Chizzonite	NULL
,	NULL
R.	NULL
&	NULL
Gately	NULL
,	NULL
M.	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
207A	NULL
(	NULL
abstr	NULL
.	NULL
)	NULL

.	NULL

Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
III	NULL
,	NULL
Hackett	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
Feldman	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Igarishi	NULL
,	NULL
K.-L.	NULL
,	NULL
Fibach	NULL
,	NULL
E.	NULL
,	NULL
Weber	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Thorner	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
Silva	NULL
,	NULL
C.	NULL
M.	NULL
&	NULL
Larner	NULL
,	NULL
A.C.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
2113-2118	NULL
.	NULL

Wilson	NULL
,	NULL
K.	NULL
C.	NULL
&	NULL
Finbloom	NULL
,	NULL
D.	NULL
$	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
11964-11968	NULL
.	NULL

Pearse	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
Feinman	NULL
,	NULL
R.	NULL
&	NULL
Ravetch	NULL
,	NULL
J.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
11305-11309	NULL
.	NULL

Reich	NULL
,	NULL
N.	NULL
,	NULL
Evans	NULL
,	NULL
B.	NULL
,	NULL
Levy	NULL
,	NULL
D.	NULL
,	NULL
Fahey	NULL
,	NULL
D.	NULL
,	NULL
Knight	NULL
,	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
6394-6398	NULL
.	NULL

Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
III	NULL
,	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
Fang	NULL
,	NULL
H.	NULL
,	NULL
Grimley	NULL
,	NULL
P.	NULL
,	NULL
Larner	NULL
,	NULL
A.	NULL
C.	NULL
&	NULL
Vande	NULL
Pol	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1477-1486	NULL
.	NULL

Kotanides	NULL
,	NULL
H.	NULL
&	NULL
Reich	NULL
,	NULL
N.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1265-1267	NULL
.	NULL

Desai	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
Quinn	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Wolitzky	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Mongini	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
Chizzonite	NULL
,	NULL
R.	NULL
&	NULL
Gately	NULL
,	NULL
M.	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
3125-3132	NULL
.	NULL

Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
&	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
421-452	NULL
.	NULL

Kornbluth	NULL
,	NULL
J.	NULL
,	NULL
Flomenberg	NULL
,	NULL
N.	NULL
&	NULL
Dupont	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

129	NULL
,	NULL
2831-2837	NULL
.	NULL

Shuai	NULL
,	NULL
K.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Prezioso	NULL
,	NULL
V.	NULL
R.	NULL
&	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
258	NULL
,	NULL
1808-1812	NULL
.	NULL

Zhang	NULL
,	NULL
X.	NULL
,	NULL
Blenis	NULL
,	NULL
J.	NULL
,	NULL
Li	NULL
,	NULL
H.-C.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
&	NULL
Chen-Kiang	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1990-1994	NULL
.	NULL

Horak	NULL
,	NULL
I.	NULL
D.	NULL
,	NULL
Gress	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Lucas	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Horak	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Waldmann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

&	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
1996-2000	NULL
.	NULL

Siegel	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
&	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
18472-18480	NULL
.	NULL

Lutticken	NULL
,	NULL
C.	NULL
,	NULL
Coffer	NULL
,	NULL
P.	NULL
,	NULL
Yuan	NULL
,	NULL
J.	NULL
,	NULL
Schwartz	NULL
,	NULL
C.	NULL
,	NULL
Caldenhoven	NULL
,	NULL
E.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Kruijer	NULL
,	NULL
W.	NULL
,	NULL
Heinrich	NULL
,	NULL
P.	NULL
C.	NULL
&	NULL
Horn	NULL
,	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

360	NULL
,	NULL
137-143	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

6	NULL
,	NULL
415-424	NULL
.	NULL

Miiller	NULL
,	NULL
M.	NULL
,	NULL
Briscoe	NULL
,	NULL
J.	NULL
,	NULL
Laxton	NULL
,	NULL
C.	NULL
,	NULL
Guschin	NULL
,	NULL
D.	NULL
,	NULL
Ziemecki	NULL
,	NULL
A.	NULL
,	NULL
Sivennoinen	NULL
,	NULL
O.	NULL
,	NULL
Harpur	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Barbieri	NULL
,	NULL
G.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Schin-dier	NULL
,	NULL
C.	NULL
,	NULL
Pellegrini	NULL
,	NULL
S.	NULL
,	NULL
Wilks	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Thie	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
&	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
366	NULL
,	NULL
129-135	NULL
.	NULL

Watling	NULL
,	NULL
D.	NULL
,	NULL
Guschin	NULL
,	NULL
D.	NULL
,	NULL
Miller	NULL
,	NULL
M.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Rogers	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Ihle	NULL
,	NULL
J.	NULL
N.	NULL
&	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
366	NULL
,	NULL
166-170	NULL
.	NULL

Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Ihle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Schlessinger	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
366	NULL
,	NULL
583-585	NULL
.	NULL

Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Miura	NULL
,	NULL
O.	NULL
,	NULL
Lai	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Cwik	NULL
,	NULL
C.	NULL
,	NULL
Liu	NULL
,	NULL
E.	NULL
T.	NULL
&	NULL
.	NULL

Ihle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
370	NULL
,	NULL
153-157	NULL
.	NULL

Gilmour	NULL
,	NULL
K.	NULL
C.	NULL
&	NULL
Reich	NULL
,	NULL
N.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
,	NULL
6850-6854	NULL
.	NULL

Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Rees	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Kaplan	NULL
,	NULL
D.	NULL
,	NULL
Shibuya	NULL
,	NULL
K.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Gupta	NULL
,	NULL
S.	NULL
,	NULL
Chen	NULL
,	NULL
Y.	NULL
Q.	NULL
,	NULL
Giri	NULL
,	NULL
J.	NULL
D.	NULL
&	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Lin	NULL
,	NULL
J.	NULL
X.	NULL
,	NULL
Migone	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Tsang	NULL
,	NULL
M.	NULL
,	NULL
Friedman	NULL
,	NULL
M.	NULL
,	NULL
Weatherbee	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Zhou	NULL
,	NULL
L.	NULL
,	NULL
Yamauchi	NULL
,	NULL
A.	NULL
,	NULL
Bloom	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Mietz	NULL
,	NULL
J.	NULL
,	NULL
John	NULL
,	NULL
$	NULL
.	NULL

&	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
331-339	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Wong	NULL
,	NULL
S.	NULL
C.	NULL
&	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
321-329	NULL
.	NULL

Stahl	NULL
,	NULL
N.	NULL
,	NULL
Farruggeila	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Boulton	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Yancopoulos	NULL
,	NULL
G.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1349-1353	NULL
.	NULL

